Toshiyuki Takasu

2.3k total citations
61 papers, 1.9k citations indexed

About

Toshiyuki Takasu is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Toshiyuki Takasu has authored 61 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Endocrinology, Diabetes and Metabolism, 31 papers in Molecular Biology and 23 papers in Surgery. Recurrent topics in Toshiyuki Takasu's work include Diabetes Treatment and Management (29 papers), Pancreatic function and diabetes (20 papers) and Metabolism, Diabetes, and Cancer (18 papers). Toshiyuki Takasu is often cited by papers focused on Diabetes Treatment and Management (29 papers), Pancreatic function and diabetes (20 papers) and Metabolism, Diabetes, and Cancer (18 papers). Toshiyuki Takasu collaborates with scholars based in Japan, Netherlands and China. Toshiyuki Takasu's co-authors include Atsuo Tahara, Eiji Kurosaki, Masanori Yokono, Masao Sasamata, Masakazu Imamura, Yuka Hayashizaki, Shoji Takakura, Hiroshi Tomiyama, Masayuki Shibasaki and Rumi Kihara and has published in prestigious journals such as Brain Research, The Journal of Infectious Diseases and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Toshiyuki Takasu

58 papers receiving 1.9k citations

Peers

Countries citing papers authored by Toshiyuki Takasu

Since Specialization

Citations

This map shows the geographic impact of Toshiyuki Takasu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toshiyuki Takasu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toshiyuki Takasu more than expected).

Fields of papers citing papers by Toshiyuki Takasu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toshiyuki Takasu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toshiyuki Takasu. The network helps show where Toshiyuki Takasu may publish in the future.

Co-authorship network of co-authors of Toshiyuki Takasu

This figure shows the co-authorship network connecting the top 25 collaborators of Toshiyuki Takasu. A scholar is included among the top collaborators of Toshiyuki Takasu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toshiyuki Takasu. Toshiyuki Takasu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effect of ipragliflozin, an SGLT2 inhibitor, on cardiac histopathological changes in a non-diabetic rat model of cardiomyopathy 2019 ·Life Sciences ·Toshiyuki Takasu, Shoji Takakura	25
2	Ipragliflozin improves mitochondrial abnormalities in renal tubules induced by a high‐fat diet 2018 ·Journal of Diabetes Investigation ·Susumu Takagi, Jinpeng Li, Yuta Takagaki, Munehiro Kitada, Kyoko Nitta, Toshiyuki Takasu, Keizo Kanasaki, Daisuke Koya	98
3	Antidiabetic effects of SGLT2 inhibitor ipragliflozin in type 2 diabetic mice fed diets containing different carbohydrate contents 2018 ·Life Sciences ·Atsuo Tahara, Toshiyuki Takasu	0
4	Prevention of progression of diabetic nephropathy by the SGLT2 inhibitor ipragliflozin in uninephrectomized type 2 diabetic mice 2018 ·European Journal of Pharmacology ·Atsuo Tahara, Toshiyuki Takasu	28
5	Effects of the SGLT2 inhibitor ipragliflozin on various diabetic symptoms and progression of overt nephropathy in type 2 diabetic mice 2018 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·Atsuo Tahara, Toshiyuki Takasu	5
6	Effects of the SGLT2 inhibitor ipragliflozin on food intake, appetite-regulating hormones, and arteriovenous differences in postprandial glucose levels in type 2 diabetic rats 2018 ·Biomedicine & Pharmacotherapy ·Atsuo Tahara, (unknown), Toshiyuki Takasu, Hiroshi Tomiyama	10
7	Characterization and comparison of SGLT2 inhibitors: Part 3. Effects on diabetic complications in type 2 diabetic mice 2017 ·European Journal of Pharmacology ·Atsuo Tahara, Toshiyuki Takasu, Masanori Yokono, Masakazu Imamura, Eiji Kurosaki	44
8	Pharmacological and clinical profile of ipragliflozin (Suglat®): a new therapeutic agent for type 2 diabetes 2015 ·Folia Pharmacologica Japonica ·Toshiyuki Takasu, Shoji Takakura, Seiji Kaku	1
9	Effects of the combination of SGLT2 selective inhibitor ipragliflozin and various antidiabetic drugs in type 2 diabetic mice 2015 ·Archives of Pharmacal Research ·Atsuo Tahara, Toshiyuki Takasu, Masanori Yokono, Masakazu Imamura, Eiji Kurosaki	6
10	Ipragliflozin, an SGLT2 inhibitor, exhibits a prophylactic effect on hepatic steatosis and fibrosis induced by choline-deficient l-amino acid-defined diet in rats 2015 ·European Journal of Pharmacology ·(unknown), Eiji Kurosaki, Toshiyuki Takasu, (unknown), Shunji Yamazaki, (unknown), Shoji Takakura	90
11	SGLT2 selective inhibitor ipragliflozin reduces body fat mass by increasing fatty acid oxidation in high-fat diet-induced obese rats 2014 ·European Journal of Pharmacology ·Masanori Yokono, Toshiyuki Takasu, Yuka Hayashizaki, Keisuke Mitsuoka, Rumi Kihara, Yuko Muramatsu, Sosuke Miyoshi, Atsuo Tahara, Eiji Kurosaki, Qun Li, Hiroshi Tomiyama, Masao Sasamata, Masayuki Shibasaki, Yasuo Uchiyama	171
12	Pharmacological profile of ipragliflozin (ASP1941), a novel selective SGLT2 inhibitor, in vitro and in vivo 2011 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·Atsuo Tahara, Eiji Kurosaki, Masanori Yokono, Daisuke Yamajuku, Rumi Kihara, Yuka Hayashizaki, Toshiyuki Takasu, Masakazu Imamura, Qun Li, Hiroshi Tomiyama, Yoshinori Kobayashi, Atsushi Noda, Masao Sasamata, Masayuki Shibasaki	96
13	Synthesis and evaluation of novel phenoxypropanolamine derivatives containing acetanilides as potent and selective β3-adrenergic receptor agonists 2009 ·Bioorganic & Medicinal Chemistry ·Tatsuya Maruyama, (unknown), Masahiko Hayakawa, Norio Seki, Takumi Takahashi, Hiroyuki Moritomo, Takayuki Suzuki, Tetsuo Matsui, Toshiyuki Takasu, Itsuro Nagase, Mitsuaki Ohta	5
14	Discovery of novel thiourea derivatives as potent and selective β3-adrenergic receptor agonists 2009 ·Bioorganic & Medicinal Chemistry ·Tatsuya Maruyama, Norio Seki, (unknown), Takayuki Suzuki, (unknown), Masahiko Hayakawa, Tetsuo Matsui, Toshiyuki Takasu, Mitsuaki Ohta	9
15	Pharmacological profile of ASP8497, a novel, selective, and competitive dipeptidyl peptidase-IV inhibitor, in vitro and in vivo 2008 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·(unknown), Atsuo Tahara, Ryosuke Nakano, (unknown), Itsuro Nagase, (unknown), Toshiyuki Takasu, Masahiko Hayakawa, Masayuki Shibasaki	10
16	Antiobesity effect of YM348, a novel 5-HT2C receptor agonist, in Zucker rats 2004 ·Brain Research ·(unknown), Rie Sonoda, Yasuharu Kimura, Toshiyuki Takasu, Masanori Suzuki, Masao Sasamata, Keiji Miyata	41
17	Atorvastatin increases hepatic fatty acid beta-oxidation in sucrose-fed rats: comparison with an MTP inhibitor 2002 ·European Journal of Pharmacology ·Toshiyuki Funatsu, Hirotoshi Kakuta, Toshiyuki Takasu, Keiji Miyata	16
18	Distribution of herpes simplex virus types 1 and 2 genomes in human spinal ganglia studied by PCR and in situ hybridization. 1997 ·American Journal of Ophthalmology ·Yoshitaka Obara, (unknown), Toshiyuki Takasu, Shin Suzuki, Hiroshi Suzuki, (unknown), (unknown), Hidenori Takahashi, (unknown), Kazuo Nagashima	3
19	Patient with both lupus anticoagulant and acute disseminated encephalomyelitis 1996 ·Clinical Rheumatology ·(unknown), Tetsuya Mizutani, (unknown), Masami Takei, Takashi Hayama, Susumu Nishinarita, Takashi Horie, Shigemasa Sawada, (unknown), (unknown), Toshiyuki Takasu	2
20	Latent herpes simplex virus type 1 in human geniculate ganglia 1992 ·Acta Neuropathologica ·Yasushi Furuta, Toshiyuki Takasu, Kazuko Sato, S. Fukuda, Yukio Inuyama, K Nagashima	75

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact